Introduction
The regulation of brain tumor development Another comprehensive review of asymmetric cell division and cancer has recently been published [2] , although the current review will be focused specifi cally on glioma and will discuss the translational implications of studies on asymmetric cell division regulators.
Cell division in mammalian brain development
As in most adult tissues, the diff erentiation 
Neuroepithelial cells and radial glia cells
The brain is developmentally derived from the neural plate, which becomes the neural tube from which neuroepithelial cells arise [3] . During a subsequent proliferative period, symmetrical cell divisions before transitioning to asymmetric cell division in order to produce the multiple cell types that make up the central nervous system [4, 5] (Table 1 ). This transition from the proliferative to the neurogenic phase occurs when Sox 1 transcription factor expression is reduced in favor of Pax 6, which drives the formation of radial glial cells over the less differentiated neuroepithelial cells [6] .
Neuroepithelial cells may produce one neuron or basal progenitor cell, also known as an intermediate progenitor, during asymmetric cell division [7] ( Table 1) . These more differentiated daughter cells lose both the apical and basal process to migrate to the subventricular zone. Basal progenitor cells divide symmetrically to produce two neurons, or rarely two basal progenitors [7] [8] [9] . In addition with each other [12, 13] (Figure 1 and Table 1 ).
Once radial glial cells become post-mitotic, they transition from Pax6 expression normally exhibited by radial glial cells to Tbr2 when they become progenitor cells and then finally Tbr1 once they reach the neuronal phenotype in the developing cortex [14, 15] .
The outer radial glial cells and outer subventricular zone
More recently, a second radial glial cell type was discovered in the subventricular zone.
These are derived from asymmetric division of radial glial cells, after which they migrate from the ventricular zone to the subventricular zone.
These cells retain the basal fiber previously belonging to the mother radial glial cell and like their mother radial glial cells express Pax 6 [16] [17] [18] . Thus they have been termed outer radial glial cells and the area that they populate is called the outer subventricular zone. Outer radial glial cells may divide asymmetrically to both self-renew and produce either a basal progenitor or neuron [17, 19] (Figure 1 and Table 1 ). This is a process which relies on integrin signaling and involves the more basally located daughter cell once again inheriting the basal fiber to become another outer radial glial cell and the more apical daughter cell undergoing differentiation [17, 20] . The outer subventricular zone in humans is much larger than in rodents and due to its high proliferative activity of outer radial glial cells and their transit amplifying progeny, it is believed to be crucial for the massive increase in neuron number in the human neocortex [21] .
It was previously thought that the neurogenic phase was the only time during which new neurons were produced [22] . However, it is now clear that neurogenesis is sustained at postnatal stages and possibly throughout adult life in both vertebrates and invertebrates alike, indeed in the human brain [23] . This occurs largely in the subventricular zone surrounding the lateral ventricles and in the subgranular zone of the dentate gyrus within the hippocampus in mammals, where there is a resident pool of stem cells derived from radial glial cells that persists throughout adulthood [24] . A recent study has also shown that cortical interneurons may have a non-epithelial stem cell origin within the human ganglionic eminences, which are transitory brain structures evident during the embryonic and fetal stages of development [25] .
This non-epithelial stem cell had not previously been reported and is characterized by the lack of radial fibers [25] . [34] . However, there is also evidence of astrocyte production through an astrocyte specific progenitor, which is derived from a glial restricted progenitor cell characterized by A2B5
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expression [35] (Table 1) . Astrocytes may also be generated locally by symmetrical division of existing astrocytes (Table 1 ) [36] . Therefore it is likely that astrocytes are generated by multiple different pathways both including and excluding glial restricted progenitor cells [37] .
Oligodendrocytes
Oligodendrocytes are the myelinating glial cells of the brain and are derived from oligodendrocyte progenitor cells characterized by platelet-derived growth factor receptoralpha, NG2 proteoglycan and Olig2 expression [38, 39] . This is a separate progenitor cell lineage than that evident for neurogenesis, although this pathway may overlap with the genesis of astrocytes [40, 41] . Wnt, Olig1 and Olig2 signaling are important for the stimulation of oligodendrocyte production [40, 42] , whereas Pax 6 has been shown to selectively inhibit production of oligodendrocytes [42] . Clonal analyses of O2A oligodendrocyte progenitor cells in vitro suggested that they initially undergo a finite number of symmetrical cell divisions, followed by a final asymmetric cell division to both self-renew and produce oligodendroglia.
The oligodendrocyte progenitor division mode at adult stages may be more evenly distributed between asymmetric and symmetric divisions [41, 43, 44 
Control of asymmetric cell division in
Drosophila neuroblasts has been thoroughly reviewed in several recent papers [2, 47, 48] . [50] [51] [52] [53] [54] . This apical complex is preferentially distributed into the self-renewing neuroblast daughter cell, whereas the basal complex becomes localized within the ganglion mother cell [55] . [59] . Moreover, when applied to Numb mutant Drosophila embryos, mammalian numb is asymmetrically distributed into the cell fated to the neuronal pathway [60] .
Similarly, the Drosophila fate determinant Brat is thought to be homologous to mammalian TRIM32, which during asymmetric cell division becomes preferentially located within the more differentiated daughter cell [61] . Musashi-1 (Msi1) is integral to the asymmetric cell division of precursor cells during Drosophila sensory organ development [69] . In mammals it has been shown to enhance Notch inhibition of Numb to increase self-renewal of neural stem cells [70] . However, when the Msi1 gene was disrupted in neural stem cells, there was no signifi cant diff erence in their ability to selfrenew [71] . Therefore, further investigation is includes astrocytoma, oligodendroglioma and ependymoma. This review is focused predominantly on astrocytoma and oligodendroglioma ( Table 2) . Glioma makes up a large proportion of brain tumor sufferers and may affect patients throughout any stage of life (Table 2) .
Recently, glioblastoma multiforme (GBM) have been classified according to four molecular subtypes based on gene expression studies. These are the proneural, neural, classical and mesenchymal molecular profiles.
The classical subtype has been characterized by EGFR mutation, and has been shown to be the variant which responds most favorably to aggressive treatment [83] . The mesenchymal subtype has a high frequency of NF1 mutations and the proneural displayed evidence of alterations in PDGFRA/IDH1 along with poor response to aggressive therapy [83] .
The only treatment combination that has improved overall survival of glioma patients is radiation in conjunction with the alkylating agent temozolomide [84] . Currently under investigation is Avastin, also known as bevacizumab, a monoclonal antibody against vascular endothelial growth factor and as such is an anti-angiogenic drug.
However, this treatment has only been able to provide symptomatic improvement for patients and ultimately makes gliomas more aggressive upon resistance development and relapse [85, 86] . Therefore the development of alternative treatment strategies is of vast importance and this review will discuss the role that asymmetric cell division controllers may have in improvement of therapy for glioma. 
Astrocytoma Oligodendroglioma
Incidence most common primary brain tumor [73] , most common childhood brain tumor (40% of all pediatric brain tumors) [74] [75] [76] [77] rarer than astrocytoma Grade Grades I and II-low grade, grade III and IV -high grade, Grade IV astrocytoma -(glioblastoma multiforme, GBM) most aggressive brain tumor currently incurable
Grades I and II -low grade, grade III -high grade Progression low grade commonly progress to higher grades generally do not progress to higher grades Treatment response chemoresistant chemoresponsive, no significant difference in survival for complete versus incomplete resections [78] survival overall survival low grade astrocytoma -4.5 years [79] , median overall survival grade III anaplastic astrocytoma-15 months [80] , median survival GBM -8 months [81, 82] overall survival anaplastic oligodendroglioma grade III -42 months [80] In hypothesis has yet to be exhaustively tested.
In an attempt to determine the glioma cell of origin, a p53/Nf2 mutation driven mouse model of glioma was utilized to show that even when the initial cell of mutation is a neural stem cell, the cell of tumor origin is in fact an oligodendrocyte progenitor cell [95] . The p53 gene is mutated in approximately 48% of anaplastic astrocytoma and 31% of GBM [118] . Mutation in p53 alone is not sufficient for astrocytoma formation [119] . However it does confer proliferative advantage to the slow dividing neural stem cells and fast proliferating progenitor cells of the subventricular zone in adult mice carrying p53 deletion [119] .
However, in mice which harbor p53 and Nf1 deletion, astrocytomas develop, the majority of which display characteristics of GBM [120] . Nf1 [123, 124] . In contrast, this same differentiation stimulus caused the cells with a wild type genetic profile or only one of these mutations to flatten and lose Nestin staining [123, 124] .
The pro-differentiation environment also resulted in increased c-Myc in the Pten and p53 double null neural stem cells. Furthermore, the resistance to differentiation stimuli was abolished when the activity of c-Myc was inhibited [123, 124] .
Some studies have shown that only selfrenewing cell types and not terminally differentiated cells are able to be genetically transformed to result in tumor formation particularly with Pten deletion [106, 110] ( Table 3 ). The tumor suppressor gene Pten has been proposed to play a role in asymmetric cell division maintenance, although further studies are required to validate this theory [125] . This proposition is based on mouse studies where Pten knockdown was localized in central nervous system tissues at mid-gestation, resulting in increased cell proliferation, cell size and decreased apoptosis, which led to increased brain size and histological abnormalities [126] . In addition, when Pten is knocked down in patient derived glioblastoma cells, the tumor inhibitor lethal giant larvae (Lgl) is phosphorylated and thus inactivated by aPKC that leads to the maintenance of the self-renewing phenotype in these cells [127] . However, differentiation of this self-renewing cancer cell population was initiated when Pten levels were restored to normal levels, when Lgl was constitutively activated and when aPKC was knocked down [127] . Therefore each of these factors are in all likelihood involved in the maintenance of asymmetric cell division in astrocytoma during tumor development and should be tested as possible targets to disrupt this cell division mode and possibly sensitize GBM cells to standard chemotherapeutic agents.
Based on the discussed studies, it is likely that there is no single cell of origin for astrocytoma, but rather that they may arise from any of the 
Tumor propagating cells
Heterogeneous cancer cell populations have been identified within brain tumors [129] [130] [131] . Furthermore, there is increased heterogeneity of marker expression and molecular profiles for TPC over neural stem cells [142] .
TPC have been identified in many human gliomas [143, 144] . Populations of TPC are able to not only recapitulate the pathophysiology of the original tumor from which they were isolated, but are also able to produce the corresponding diversity of cell populations within the tumor mass in an experimental setting. Thus, a single glioma TPC is able to produce multiple heterogeneous cell types [139, 145] . It has been proposed that a combination of asymmetric and symmetric cellular divisions allows TPC to both expand the tumor mass and produce differential progeny.
Evidence of this is presented in an in vitro human gliomas of differing grade [150, 151] .
This poorer outcome could be due to increased asymmetric cell divisions in the PROX1 labeled cell populations within these tumors [152] .
Asymmetric cell division has been proposed to contribute to therapy resistance in the slow replicating stem-like TPC populations of other cancer types including gastric cancer and acute lymphoblastic leukemia [153, 154] . Therefore, a similar mechanism may confer poorer outcome to brain tumor patients with malignancies which contain a proportion of asymmetrically dividing stem-like TPC.
As previously discussed, Msi1 is a RNAbinding protein and functions to enhance Notch signaling and thus inhibit Numb, promoting neural stem cell self-renewal [70] . In a study of primary human central nervous system tumors, Msi1 expression was increased, particularly in malignant gliomas, when compared to nonneoplastic tissue and other brain tumor types [155] . This expression was related to both tumor malignancy and proliferation rate [155, 156] .
In GBM cells with shRNA knockdown of Msi1, an increased number of cells were evident in G2 or M phase of the cell cycle, meaning that this knockdown increased the time these cells spent in mitosis [157] . Further, when these cells were orthotopically xenografted into NOD/SCID mice, the resultant tumors were 96.6% smaller than their non-Msi1 knockdown counterparts [157] . Therefore, further studies should be performed to determine if targeting Msi1 could be used to improve treatment of gliomas by disrupting asymmetric cell division of TPC and possibly improving tumor response to standard glioma treatment strategies.
Numb is a classical controller of asymmetric cell division and has been found to be asymmetrically segregated between daughter cells of dividing GBM stem-like TPC [158] .
In this study, Numb was localized into the CD133-positive daughter cell and excluded from its CD133-negative counterpart [158] .
In contrast, a study using Lgl1 knockout mice showed that brain progenitor cells are only able to symmetrically distribute Numb between daughter cells, resulting in a failure of asymmetric cell division [159] . This led to a hyperproliferative phenotype where cells lack features of differentiation [159] . These data suggest that normal Numb function and distribution is required for asymmetric cell division of TPC, which may inhibit excessive proliferation of this population, but may also contribute to treatment resistance and tumor propagation in astrocytomas.
Supporting this, studies have shown that
Numb is expressed in all grades of astrocytomas [160] . Numb deletions or very low levels of Numb have been found within the proneural GBM subtype, whereas much higher expression is evident in the classical and mesenchymal subtypes, which are associated with comparatively poorer outcomes for patients [158] . Thus, increased Numb in astrocytoma, with non-neoplastic tissue [161, 162] . Although Numb acts to inhibit Notch signaling and
Numb has been associated with poor treatment response in GBM, Notch is also a hallmark of poorer prognosis for glioma patients [163] .
Notch signaling has been shown to induce increased colony forming capacity, increased self-renewal and decreased differentiation in GBM neurosphere cultures [164] . Similarly, in neural stem cells, NOTCH2 activation results in hyperplasia of the neurogenic niche and impaired neuronal differentiation. In this same study, Notch 2 signaling in GBM TPC resulted in enhanced proliferation and decreased apoptosis [165] .
NOTCH activation can be promoted by the neural stem cell niche endothelial cells [166, 167] .
This may in part explain why tumors located in close proximity to the ventricles produce poorer patient outcomes [128] . In conjunction, The Wnt pathway is frequently mutated in astrocytoma and is associated with hereditary syndromes that predispose patients to central nervous system tumor formation [177, 178] . Wnt, through the actions of beta catenin, is important for the maintenance of asymmetric cell divisions in the brain [179, 180] .
GBM cells treated with Wnt ligands exhibit decreased proliferation and promotion of the differentiation pathway [181] . Another study has shown that the Wnt pathway antagonist, recombinant sFRP1, is effective at inhibiting patient derived glioma TPC self-renewal and proliferation [182] . Polo-like kinase 1 (Plk1) is an important component of the machinery that governs spindle orientation and mitotic progression of mammalian neural progenitor cells [184] and has been shown to be important for asymmetric cell division in non-mammalian experimental models [185, 186] . Plk1 expression is increased in a manner correlated with degree of anaplasia in human glioma cell lines [187] . Similarly, astrocytoma TPC show an increase in the expression of Plk1 more than 100 fold above that evident for non-neoplastic astrocytes [188] . Furthermore, inhibition of Plk1 in these TPC decreased proliferation and caused G2/M arrest, ultimately leading to apoptosis [188] . Concurrently, there was a decrease in SOX2 marker expression with Plk1 inhibition, indicating that the TPC lost some of their stem cell properties [188] . Therefore it is possible that 
Tumor microenvironment and cell division mode
As previously discussed for glioma, CD133 has been shown to be asymmetrically distributed between daughter cells suggesting that glioma TPC undergo asymmetric cell divisions. In GBM cell lines established from surgical tissue samples, the CD133-positive cells showed increased rate of proliferation in neurosphere culture conditions and increased potential for neuronal differentiation [190] . Whether these asymmetric cell divisions are part of a tumor cell hierarchy similar to that generated by radial glial cells in the developing brain remains to be determined.
In brain tissue placed under hypoxic conditions stem and progenitor cells populations expand [191] . Astrocytomas, in particularly GBM, commonly contain areas within the center of the tumor that are hypoxic due to the inadequate expansion of blood vessels for the nutritional needs of the neoplastic mass [192] . It is thought that these hypoxic regions enrich the tumor for TPC, in a similar manner to the normal brain, which under hypoxic conditions is enriched for neural stem cells [191] . This is supported by the fact that TPC have been found to be most prevalent within the center or inner core of GBM tumor masses, where hypoxic environments are commonly found [193] .
CD133 expression increases when GBM cells are cultured in 7% oxygen, compared with 20% oxygen [194] . Low oxygen also decreased the proliferation and enhanced the differentiation capacity of these cells [194] .
Similarly, when GBM cell lines were cultured in 21% oxygen and hypoxic conditions of 3% oxygen, the CD133-positive content of the cell lines were altered from 69% to 92%
respectively [195] . Another effect of hypoxic conditions is an increase in the expression of Notch pathway ligands in GBM [196] . Further, in patient derived GBM TPC, culture in hypoxia not only increased CD133 expression, but also increased the ability of the cells to form neurospheres [197] . These data suggest that culture in low oxygen levels selects for CD133-labeled TPC cells or preferentially promote their expansion, which may be a predominantly asymmetrically dividing population. Supporting this, asymmetric cell division has previously been shown to be increased in lung cancer cells upon exposure to a hypoxic environment [198] . 
